Trials / Completed
CompletedNCT03644004
Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)
Descriptive Study of the Diabetes Mellitus, Type 2 Diagnosis Methods During Postpartum Period in Patients With Medical History of Gestational Diabetes Whom Benefited an Educational Therapy Session.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 173 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Diabetes mellitus, type 2, is a chronic disease which can be linked with many complications in connexion with impaired blood glucose balance. It diagnosis in risky subjects such as in patients with medical history of gestational diabetes is therefore imperative to prevent its complications. Actual guidelines recommend an oral tolerance glucose test, measuring glucose levels after oral glucose intake (75g), between 6 an 12 weeks after childbirth. But studies reveal a low diagnosis rate. The study of the current practices of diagnosis methods seem to be essential in order to improve this diagnosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | frequency of diabetes mellitus, type 2, diagnosis in patients with medical history of gestational diabetes. | Patients will be contacted by mail with sending of the information notice to ask them to participate in the study. If they don't reply, the subjects will be called by phone by the investigator to collect their non opposition of participation at the study. During this call, the investigator will be able to answer all the questions about the study. The report of this telephone conversation will be register in the medical file of the patient. Then, we will collect informatic data from the hospital concerning the patients. After that they will be contacted by phone to answer a survey. Beside, another secure survey will be send by email to each patient's family doctor. To finish, crossing data between those of the patients and the family doctor and anonymisation of the data. |
Timeline
- Start date
- 2018-10-30
- Primary completion
- 2019-02-13
- Completion
- 2019-02-13
- First posted
- 2018-08-23
- Last updated
- 2019-08-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03644004. Inclusion in this directory is not an endorsement.